arrow
Back
S

Susan O’Brien

university of california irvine

89H-index
692Paper Count
3.7WCitation Count
Published Papers 104
Publication Date
errShare
errSave
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)
err2025-07-08
err0
errOAAI
errMazyar Shadman; Jennifer R. Brown; Rhys Williams; Leyla Mohseninejad; Keri Yang; Pal Rakonczai; Nicole Lamanna; Sheng Xu; Aileen Cleary Cohen; Susan M. O’Brien; Alessandra Tedeschi; Constantine S. Tam
errShare
errSave
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL
err2025-05-14
err0
errOAAI
errJohn N. Allan; Tao Ran; Zhijie Ding; Jinghua He; Alex Bokun; Zaina P. Qureshi; Susan M. O’Brien
errShare
errSave
First-Line Treatment Choice and Risk of Other Malignancies in US Veterans Diagnosed with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errMa, Helen; Parikh, Sameer A.; Azevedo, Roberta Santos; O'Brien, Susan M.; Gupta, Pankaj; Ferrajoli, Alessandra
errShare
errSave
Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errStephens, Deborah M.; Stewart, Chris; Avruch, Liza; Coombs, Catherine C.; Danilov, Alexey; Hill, Brian T.; Shadman, Mazyar; Gerrie, Alina S.; Jensen, Christopher E.; Hoffmann, Marc; Winter, Allison M.; Ermann, Daniel A.; Barr, Paul M.; O'Brien, Susan M.; Koffman, Brian; Byrd, John C.
errShare
errSave
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies
err2024-08-21
err2
errOAAI
errDesai, Pinkal; Lonial, Sagar; Cashen, Amanda; Kamdar, Manali; Flinn, Ian; O'Brien, Susan; Garcia, Jacqueline S.; Korde, Neha; Moslehi, Javid; Wey, Margaret; Cheung, Patricia; Sharma, Shringi; Olabode, Damilola; Chen, Hong; Ali Syed, Firasath; Liu, Mary; Saeh, Jamal; Andrade-Campos, Marcio; Kadia, Tapan M.; Blachly, James S.
errShare
errSave
Chronic lymphocytic leukaemia
errLANCET
IF88.5
err2024-08-01
err2
PREAI
errJain, Nitin; Wierda, William G.; O'Brien, Susan
errShare
errSave
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL
err2024-06-14
err1
errOAAI
errZhao, Yaqi; Laird, A. Douglas; Roberts, Kathryn G.; Yafawi, Rolla; Kantarjian, Hagop; DeAngelo, Daniel J.; Stelljes, Matthias; Liedtke, Michaela; Stock, Wendy; Goekbuget, Nicola; O'Brien, Susan; Jabbour, Elias; Cassaday, Ryan D.; Loyd, Melanie R.; Olsen, Scott; Neale, Geoffrey; Liu, Xueli; Vandendries, Erik; Advani, Anjali; Mullighan, Charles G.
errShare
errSave
TREATMENT PATTERNS ANALYSIS IN PATIENTS WITH RARE AUTOINFLAMMATORY DISEASES IN THE UNITED STATES
err2024-06-01
err0
PREAI
errYasar, N.; O'brien, S.; Costa, K. Peres Da; Toto, W.; Patel, A.; Akhras, K.
errShare
errSave
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
err2023-12-13
err0
errOAAI
errBrown, Jennifer R.; Eichhorst, Barbara; Hillmen, Peter; Jurczak, Wojciech; Kazmierczak, Maciej; Lamanna, Nicole; O'Brien, Susan M.; Tam, Constantine S.; Qiu, Lugui; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Ferrajoli, Alessandra; Ganly, Peter S.; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A.; Salmi, Tommi; Wang, Megan-Der-Yu; Fu, Lina; Li, Jessica; Wu, Kenneth; Cohen, Aileen; Shadman, Mazyar
errShare
errSave
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia
err2023-08-23
err6
errOAAI
errUjjani, Chaitra; Gooley, Ted A.; Spurgeon, Stephen E.; Stephens, Deborah M.; Lai, Catherine; Broome, Catherine M.; O'Brien, Susan; Zhu, Haiying; Laing, Kerry J.; Winter, Allison M.; Pongas, Georgios; Greninger, Alexander L.; Koelle, David M.; Siddiqi, Tanya; Davids, Matthew S.; Rogers, Kerry A.; V. Danilov, Alexey; Sperling, Amy; Tu, Brian; Sorensen, Tyler; Launchbury, Kelsey; Burrow, Carlissa J.; Quezada, Genesis; Hill, Joshua A.; Shadman, Mazyar; Thompson, Philip A.
errShare
errSave
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
err2023-06-14
err6
errOAAI
errWoyach, Jennifer A.; Ghia, Paolo; Byrd, John C.; Ahn, Inhye E.; Moreno, Carol; O'Brien, Susan M.; Jones, Daniel; Cheung, Leo W. K.; Chong, Elizabeth; Kwei, Kevin; Dean, James P.; James, Danelle F.; Wiestner, Adrian
errShare
errSave
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia
err2023-05-02
err20
errOAAI
errKantarjian, Hagop; Haddad, Fadi G.; Jain, Nitin; Sasaki, Koji; Short, Nicholas J.; Loghavi, Sanam; Kanagal-Shamanna, Rashmi; Jorgensen, Jeffrey; Khouri, Issa; Kebriaei, Partow; Alvarado, Yesid; Kadia, Tapan; Paul, Shilpa; Garcia-Manero, Guillermo; Dabaja, Bouthaina; Yilmaz, Musa; Jacob, Jovitta; Garris, Rebecca; O'Brien, Susan; Ravandi, Farhad; Jabbour, Elias
errShare
errSave
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
err2023-03-31
err25
errOAAI
errAdvani, Anjali S.; Moseley, Anna; O'Dwyer, Kristen M.; Wood, Brent L.; Park, Jae; Wieduwilt, Matthew; Jeyakumar, Deepa; Yaghmour, George; Atallah, Ehab L.; Gerds, Aaron T.; O'Brien, Susan M.; Liesveld, Jane L.; Othus, Megan; Litzow, Mark; Stone, Richard M.; Sharon, Elad; Erba, Harry P.
errShare
errSave
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia
err2023-02-24
err2
errOAAI
errLee, Benjamin J. J.; Griffin, Shawn P. P.; Doh, Jean; Kongtim, Piyanuch; Chan, Alexandre; O'Brien, Susan; Jeyakumar, Deepa; Ciurea, Stefan O. O.
errShare
errSave
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
err2023-01-26
err214
errOAAI
errBrown, J. R.; Eichhorst, B.; Hillmen, P.; Jurczak, W.; Kazmierczak, M.; Lamanna, N.; O'Brien, S. M.; Tam, C. S.; Qiu, L.; Zhou, K.; Simkovic, M.; Mayer, J.; Gillespie-Twardy, A.; Ferrajoli, A.; Ganly, P. S.; Weinkove, R.; Grosicki, S.; Mital, A.; Robak, T.; Osterborg, A.; Yimer, H. A.; Salmi, T.; Wang, M. -D. -Y.; Fu, L.; Li, J.; Wu, K.; Cohen, A.; Shadman, M.
errShare
errSave
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch
err2022-09-14
err7
PREAI
errLee, Benjamin J.; Griffin, Shawn P.; Doh, Jean; Chan, Alexandre; O'Brien, Susan; Jeyakumar, Deepa; Ciurea, Stefan O.; Becker, Pamela S.; Kongtim, Piyanuch
errShare
errSave
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts
err2022-08-08
err1
errOAAI
errBarr, Paul M.; Tedeschi, Alessandra; Wierda, William G.; Allan, John N.; Ghia, Paolo; Vallisa, Daniele; Jacobs, Ryan; O'Brien, Susan; Grigg, Andrew P.; Walker, Patricia; Zhou, Cathy; Ninomoto, Joi; Krigsfeld, Gabriel; Tam, Constantine S.
errShare
errSave
Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies
err2021-12-23
err28
errOAAI
errAllan, John N.; Pinilla-Ibarz, Javier; Gladstone, Douglas E.; Patel, Krish; Sharman, Jeff P.; Wierda, William G.; Choi, Michael Y.; O'Brien, Susan M.; Shadman, Mazyar; Davids, Matthew S.; Pagel, John M.; Yimer, Habte A.; Ward, Renee; Acton, Gary; Taverna, Pietro; Combs, Daniel L.; Fox, Judith A.; Furman, Richard R.; Brown, Jennifer R.
errShare
errSave